Antimicrobial resistance means the age of antibiotics – when humanity has had the luxury of fixing or preventing all manner of disease with a simple biological agent in a capsule – is coming to an end. Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) CEO James Graham talks to Proactive’s Susanna Nelson about how we stay one step ahead in the fight against deadly pathogens and avoid the next superbug.
Advertisement Go to Proactive UK Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com